Prediction of cancer cell sensitivity to natural products based on genomic and chemical properties.

about

Integration of phytochemicals and phytotherapy into cancer precision medicine.

P2860

Q38780465-8D2168BE-CA7A-4492-A8F1-7629BB467D52

P2860

Prediction of cancer cell sensitivity to natural products based on genomic and chemical properties.

Item

http://www.wikidata.org/entity/Q36350628

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Prediction of cancer cell sens ...... nomic and chemical properties.

@ast

Prediction of cancer cell sens ...... nomic and chemical properties.

@en

type

Item

label

Prediction of cancer cell sens ...... nomic and chemical properties.

@ast

Prediction of cancer cell sens ...... nomic and chemical properties.

@en

prefLabel

Prediction of cancer cell sens ...... nomic and chemical properties.

@ast

Prediction of cancer cell sens ...... nomic and chemical properties.

@en

P1476

Prediction of cancer cell sens ...... enomic and chemical properties

@en

P2093

Qiaoyue Yang

http://www.w3.org/2001/XMLSchema#string

Qiuying Ding

http://www.w3.org/2001/XMLSchema#string

Wenna Zhang

http://www.w3.org/2001/XMLSchema#string

Yan Chen

http://www.w3.org/2001/XMLSchema#string

Zhenyu Yue

http://www.w3.org/2001/XMLSchema#string

P2860

A census of human cancer genes

PaDEL-descriptor: An open source software to calculate molecular descriptors and fingerprints

An introduction to ROC analysis

Systematic identification of genomic markers of drug sensitivity in cancer cells

Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines

Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study.

New tricks for an old natural product: discovery of highly potent evodiamine derivatives as novel antitumor agents by systemic structure-activity relationship analysis and biological evaluations.

International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial.

Natural IAP inhibitor Embelin enhances therapeutic efficacy of ionizing radiation in prostate cancer.

Synthesis and evaluation of 8,4'-dideshydroxy-leinamycin revealing new insights into the structure-activity relationship of the anticancer natural product leinamycin.

P304

e1425

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7717/PEERJ.1425

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yongming Lu

Junfeng Xia

P577

2015-11-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

284771033

http://www.w3.org/2001/XMLSchema#string

P698

26644976

http://www.w3.org/2001/XMLSchema#string

P932

4671159

http://www.w3.org/2001/XMLSchema#string

Prediction of cancer cell sensitivity to natural products based on genomic and chemical properties.

about

P2860

P2860

Prediction of cancer cell sensitivity to natural products based on genomic and chemical properties.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932